Correlation Between Mineralys Therapeutics, and GeoVax Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and GeoVax Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and GeoVax Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and GeoVax Labs, you can compare the effects of market volatilities on Mineralys Therapeutics, and GeoVax Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of GeoVax Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and GeoVax Labs.

Diversification Opportunities for Mineralys Therapeutics, and GeoVax Labs

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mineralys and GeoVax is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and GeoVax Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeoVax Labs and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with GeoVax Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeoVax Labs has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and GeoVax Labs go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and GeoVax Labs

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.21 times more return on investment than GeoVax Labs. However, Mineralys Therapeutics, Common is 4.83 times less risky than GeoVax Labs. It trades about 0.02 of its potential returns per unit of risk. GeoVax Labs is currently generating about -0.01 per unit of risk. If you would invest  1,257  in Mineralys Therapeutics, Common on August 29, 2024 and sell it today you would lose (5.00) from holding Mineralys Therapeutics, Common or give up 0.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  GeoVax Labs

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
GeoVax Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Mineralys Therapeutics, and GeoVax Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and GeoVax Labs

The main advantage of trading using opposite Mineralys Therapeutics, and GeoVax Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, GeoVax Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeoVax Labs will offset losses from the drop in GeoVax Labs' long position.
The idea behind Mineralys Therapeutics, Common and GeoVax Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences